Ben Derman

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Ben Derman

Jul 14, 2024, 02:56 | Drugs

Belamaf-based triplet regimens are effective in patients with R/R multiple myeloma - ASCO

ASCO shared on X: "The DREAMM-7 and DREAMM-8 studies established the effectiveness of belamaf-based triplet…

Jun 12, 2024, 05:15 | Blog

Brand new episode on updates in Myeloma MRD - Blood Cancer Talks

Ben Derman, Assistant Professor at the University of Chicago, recently shared a post by Blood…

May 31, 2024, 09:24 | Insight

Vincent Rajkumar: International Myeloma Working Group guidelines CAR-T cell treatment in myeloma by Yi Lin

Vincent Rajkumar shared on X: "Just out: International Myeloma Working Group guidelines CAR-T cell treatment…

Apr 18, 2024, 13:58 | Insight

Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma

Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…

Aug 16, 2023, 19:07 | Drugs

Ben Derman: Some thoughts on Elrantamab in light of approval.

Dr. Ben Derman, Assistant Professor at the University of Chicago, recently shared in a Twitter…

All: 5 Posts: 1 - 100